TusPark carries torch for Cambridge-China collaborations
TusPark UK has entered the second annual Cambridge China Centre UK/China Business Award in Business Weekly’s 30th Anniversary competition. Abcam is the reigning Cambridge-China business champion having won the inaugural prize in March.
TusPark UK is a magnificent ambassador for two-way trade between the territories and its flagship Bio-Innovation Centre at Cambridge Science Park is already making big headlines through the quality of its initial tenant companies.
TusPark is part of China’s largest family of nearly 300 innovation spaces – present in every major city in China – and its mission is to help startups, maturer businesses and other organisations in the UK to enter the Chinese market easily and securely.
It has invested in local businesses since its much-trumpeted arrival in Cambridge and the anchor tenants at the Bio-Innovation Centre are world leaders in their respective fields.
Turbocharged cell therapies startup Mogrify recently became the anchor tenant at the Centre; the company is hiring big and fast at present under inspirational CEO Dr Darrin Disley.
Mogrify is exploiting transformational technology that can convert any mature cell type into any other mature cell type without going through a pluripotent stem cell – or even a progenitor cell-state. It has taken 12,000 sq ft of laboratory and office space at the Bio-Innovation Centre.
That initial success was swiftly built upon as genomics trailblazer Novogene Europe upgraded and relocated its first European Genomic Sequencing Centre to TusPark UK’s Science Park hub.
The Novogene Europe subsidiary was established in 2014 to address the European market for NGS and expand Novogene’s business in Europe. Novogene Europe now provides leading edge services and solutions to customers in over 30 countries in Europe.
Novogene’s comprehensive service offering at its Cambridge Genomic Sequencing Centre includes human genome sequencing, plant and animal genome sequencing, transcriptome sequencing, metagenome sequencing, and lanes sequencing.
Additional services are planned for the near future enabling Novogene Europe to provide even more optimised solutions for clients based on their research goals.
The move to the Bio-Innovation Centre has enabled Novogene’s Cambridge Genomic Sequencing Centre to expand its operation and continue to provide unsurpassed turnaround times and guaranteed data quality.
With a professional team recruited from all over the world, the Centre offers leading-edge Next Generation Sequencing services and solutions for all types of projects.
The lab is now equipped with a variety of platforms, including an automatic system for library preparation, multiple NovaSeq 6000s and High Performance Computing Clusters. Compared to other platforms, NovaSeq6000 delivers higher throughput and output in a shorter run cycle to meet the requirements for comprehensive research. Together with the supercomputing platforms, Novogene Cambridge Genomic Sequencing Centre is now capable of performing more than 280,000 human WGS analysis per year.
Dr David Chaplin, TusPark’s general manager of the Bio-Innovation Centre, said: “We are delighted to welcome Novogene to the Bio-Innovation Centre. Emerging technologies like NGS play critical roles in human health, environmental protection, plant and animal breeding and microbial remediation. The relocation of Novogene Cambridge Genomic Sequencing Centre is a fantastic new addition to the Cambridge Science Park.”
We welcome entries for the Cambridge-China Award from any business trading successfully in China or collaborating with Chinese partners – regardless of industry sector. You can enter online or by emailing Tony Quested directly: tquested [at] businessweekly.co.uk (subject: Cambridge-China%20Award) . Business Weekly judges this unique award with Cambridge China Centre.
• PHOTOGRAPH: Yvonne Chien of Abcam (centre) receiving the inaugural Cambridge China Centre UK/China Business Award from Jinzhao Li who heads up the Cambridge China Centre